Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials

Zhi-Yong Pan, Yu-Hang Zhao, Wen-Hong Huang, Zhi-Ze Xiao, Zhi-Qiang Li Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, PR China Purpose: The aim of this study was to assess the neuroprotective effect of progesterone administration on severe traumatic brain injury (T...

Full description

Bibliographic Details
Main Authors: Pan ZY, Zhao YH, Huang WH, Xiao ZZ, Li ZQ
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/effect-of-progesterone-administration-on-the-prognosis-of-patients-wit-peer-reviewed-article-DDDT
_version_ 1818287419863072768
author Pan ZY
Zhao YH
Huang WH
Xiao ZZ
Li ZQ
author_facet Pan ZY
Zhao YH
Huang WH
Xiao ZZ
Li ZQ
author_sort Pan ZY
collection DOAJ
description Zhi-Yong Pan, Yu-Hang Zhao, Wen-Hong Huang, Zhi-Ze Xiao, Zhi-Qiang Li Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, PR China Purpose: The aim of this study was to assess the neuroprotective effect of progesterone administration on severe traumatic brain injury (TBI) for different follow-up periods and administration route by completing a meta-analysis of randomized clinical trials (RCTs).Methods: A systematic literature search of PubMed, Embase, and Cochrane databases and the Web of Science (from establishment of each to September 1, 2018) was performed to identify original RCTs that evaluated the associations between progesterone treatment and the prognosis of patients with severe TBI.Results: Eight RCTs enrolling 2,251 patients with severe TBI were included. Within 3 months post-injury, patients with progesterone administration had a lower mortality (risk ratio [RR] =0.59; 95% CI [0.42–0.81], P=0.001) and better neurologic outcomes (RR =1.51; 95% CI [1.12–2.02], P=0.007) than those who received placebo. However, these differences did not persist at 6 months post-injury for mortality (RR =0.96; 95% CI [0.65–1.41], P=0.83) or neurologic outcomes (RR =1.09; 95% CI [0.93–1.27], P=0.31). The analysis stratified by administration route showed that beneficial effects were only observed in patients who received progesterone intramuscularly (RR =1.61, 95% CI [1.19–2.18], P=0.002); no benefit was observed with intravenous administration (RR =0.99, 95% CI [0.91–1.07], P=0.75).Conclusion: Progesterone administration improved the clinical outcomes of severe TBI patients within 3 months but may not have significant long-term benefits 6 months post-injury. Keywords: progesterone, severe traumatic brain injury, neuroprotection 
first_indexed 2024-12-13T01:40:12Z
format Article
id doaj.art-a9e85e0b37f945169ae43dc59c86f8e6
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-13T01:40:12Z
publishDate 2019-01-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-a9e85e0b37f945169ae43dc59c86f8e62022-12-22T00:03:46ZengDove Medical PressDrug Design, Development and Therapy1177-88812019-01-01Volume 1326527343468Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trialsPan ZYZhao YHHuang WHXiao ZZLi ZQZhi-Yong Pan, Yu-Hang Zhao, Wen-Hong Huang, Zhi-Ze Xiao, Zhi-Qiang Li Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, PR China Purpose: The aim of this study was to assess the neuroprotective effect of progesterone administration on severe traumatic brain injury (TBI) for different follow-up periods and administration route by completing a meta-analysis of randomized clinical trials (RCTs).Methods: A systematic literature search of PubMed, Embase, and Cochrane databases and the Web of Science (from establishment of each to September 1, 2018) was performed to identify original RCTs that evaluated the associations between progesterone treatment and the prognosis of patients with severe TBI.Results: Eight RCTs enrolling 2,251 patients with severe TBI were included. Within 3 months post-injury, patients with progesterone administration had a lower mortality (risk ratio [RR] =0.59; 95% CI [0.42–0.81], P=0.001) and better neurologic outcomes (RR =1.51; 95% CI [1.12–2.02], P=0.007) than those who received placebo. However, these differences did not persist at 6 months post-injury for mortality (RR =0.96; 95% CI [0.65–1.41], P=0.83) or neurologic outcomes (RR =1.09; 95% CI [0.93–1.27], P=0.31). The analysis stratified by administration route showed that beneficial effects were only observed in patients who received progesterone intramuscularly (RR =1.61, 95% CI [1.19–2.18], P=0.002); no benefit was observed with intravenous administration (RR =0.99, 95% CI [0.91–1.07], P=0.75).Conclusion: Progesterone administration improved the clinical outcomes of severe TBI patients within 3 months but may not have significant long-term benefits 6 months post-injury. Keywords: progesterone, severe traumatic brain injury, neuroprotection https://www.dovepress.com/effect-of-progesterone-administration-on-the-prognosis-of-patients-wit-peer-reviewed-article-DDDTprogesteronesevere traumatic brain injuryneuroprotectionrandomized clinical trialsmeta-analysis
spellingShingle Pan ZY
Zhao YH
Huang WH
Xiao ZZ
Li ZQ
Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
Drug Design, Development and Therapy
progesterone
severe traumatic brain injury
neuroprotection
randomized clinical trials
meta-analysis
title Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
title_full Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
title_fullStr Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
title_full_unstemmed Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
title_short Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials
title_sort effect of progesterone administration on the prognosis of patients with severe traumatic brain injury a meta analysis of randomized clinical trials
topic progesterone
severe traumatic brain injury
neuroprotection
randomized clinical trials
meta-analysis
url https://www.dovepress.com/effect-of-progesterone-administration-on-the-prognosis-of-patients-wit-peer-reviewed-article-DDDT
work_keys_str_mv AT panzy effectofprogesteroneadministrationontheprognosisofpatientswithseveretraumaticbraininjuryametaanalysisofrandomizedclinicaltrials
AT zhaoyh effectofprogesteroneadministrationontheprognosisofpatientswithseveretraumaticbraininjuryametaanalysisofrandomizedclinicaltrials
AT huangwh effectofprogesteroneadministrationontheprognosisofpatientswithseveretraumaticbraininjuryametaanalysisofrandomizedclinicaltrials
AT xiaozz effectofprogesteroneadministrationontheprognosisofpatientswithseveretraumaticbraininjuryametaanalysisofrandomizedclinicaltrials
AT lizq effectofprogesteroneadministrationontheprognosisofpatientswithseveretraumaticbraininjuryametaanalysisofrandomizedclinicaltrials